PHS
PFM Health Sciences Portfolio holdings
AUM
$988M
1-Year Est. Return
67.93%
This Fund
S&P 500
1 Year Est. Return
+67.93%
AUM
$1.17B
AUM Growth
+$18.3M
(+1.6%)
Holding
82
Top Buys
| 1 | +$20.9M | |
| 2 | +$20.2M | |
| 3 | +$19.9M | |
| 4 |
Merck
MRK
|
+$19.5M |
| 5 |
Elevance Health
ELV
|
+$18.9M |
Top Sells
| 1 | +$31.9M | |
| 2 | +$31.9M | |
| 3 | +$27.8M | |
| 4 |
Molina Healthcare
MOH
|
+$25.5M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
+$23.6M |
Sector Composition
| 1 | Healthcare | 97.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
76
Alnylam Pharmaceuticals
ALNY
$41.8B
| – | – |
-72,220
|
|
||
77
BioMarin Pharmaceuticals
BMRN
$10.4B
| – | – |
-178,319
|
|
||
|
BPMC
78
DELISTED
Blueprint Medicines
BPMC
| – | – |
-48,444
|
|
||
79
Danaher
DHR
$125B
| – | – |
-161,413
|
|
||
80
Erasca
ERAS
$7.04B
| – | – |
-1,072,224
|
|
||
81
State Street SPDR S&P Biotech ETF
XBI
$8.67B
| – | – |
0
|
|